Oscar Health stock is considered undervalued with a fair value of $49.90 compared to the current market price of $30.80, justifying a reiterated buy recommendation despite low conviction.
Source Post
Oscar Health Stock Analysis: Buy or Sell?
Aug 17, 2026
Oscar Health is showing significant growth in membership and revenue, alongside dramatic improvements in operating profit margins and returns on invested capital, driven by AI automation. Despite trading near its 52-week high, the stock is considered undervalued based on a discounted cash flow model, with a fair value of $49.90 compared to the current market price of $30.80. The creator reiterates a buy recommendation but expresses low conviction due to the company's relatively short operating history.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.